IPO Issue Details
Issue Price / Price Band₹84 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size1,600 Shares per Lot
Total Issue Size12,91,200 shares (aggregating up to ₹10.85 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenTue, 07 Nov 2023
Subscription CloseThu, 09 Nov 2023
Anchor AllotmentMon, 06 Nov 2023
Basis of AllotmentWed, 15 Nov 2023
Initiation of RefundsThu, 16 Nov 2023
Credit of Shares to DematFri, 17 Nov 2023
Listing DateMon, 20 Nov 2023
UPI Mandate Deadline2023-11-09
Application & Investment Details
Retail — Min (1 Lots)₹1,34,400 — 1,600 shares
Retail — Max (13 Lots)₹1,747,200 (13 Lots)
HNI — Min (2 Lots)₹2,68,800 — 3,200 shares
EPS (Pre-IPO)₹6.81
P/E Ratio (Pre-IPO)12.33x
P/E Ratio (Post-IPO)12x
Net Offer to Public12,25,600 shares (aggregating up to ₹10.30 Cr)
Reserved for Market Maker65,600 shares (aggregating up to ₹0.5510 Cr)
Pre-IPO Promoter Holding30,00,000 shares
Post-IPO Promoter Holding42,91,200 shares
About Sunrest Lifescience Ltd
Incorporated in 2017, Sunrest Lifescience Limited offers a diverse range of healthcare and personal care products.The company's product range includes Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Sunrest Lifescience's product portfolio encompasses an extensive range of drugs such as Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical, and Anti-inflammatory.The company gets its products manufactured by third-party pharma product manufacturers which also includes Trilend Pharmaceuticals Private Limited (Trilend), a Sunrest group company. The company has 43 third-party manufacturers across these states: Gujarat, Punjab, Maharashtra, Haryana, Himachal Pradesh, Uttarakhand and Madhya Pradesh.Sunrest Lifescience's clientele includes stockists and Super Stockists & in turn, it is available at Chemist shops, Dispensaries, Hospitals, etc.With 18 Registered Trademarks for 32 products, Sunrest Lifescience is committed to delivering high-quality products to its customers.
Objects of the Issue
Sunrest Lifescience Ltd proposes to utilise the net proceeds from the Issue for the following objects:
1
Meeting Working Capital Requirements
8.55
2
General Corporate Purpose
1.40
Shareholding & Lock-in
Pre-IPO Promoter Holding
30,00,000 shares
Post-IPO Promoter Holding
42,91,200 shares